Prascend (pergolide mesylate), dopamine receptor agonist, is the first and only FDA-approved treatment for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each tablet contains 1 mg of pergolide mesylate. For oral use in horses.
Prascend (pergolide mesylate), 1 mg tab
Prescription items are non-returnable
Boehringer Ingelheim offers a rebate program when purchasing from a veterinarian! Contact our office to find out the current rebate available on Prascend.